SBIR/STTR Research Award
Antimicrobial catheters with cell and tissue compatibility
Award amount
$1,491,267Program and phase
SBIR · Phase IIAward year
2016Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- POLYMER EXPLORATION GROUP, LLC
- Proposal award date
- 2016-09-20
- Contract end date
- 2019-08-31
- UEI
- Not reported
- Solicitation number
- PA15-269
- Topic code
- 300
Research abstract
Polymer Exploration Group LLC PA Abstract
Project Title Antimicrobial catheters with cell and tissue compatibility
Abstract
Catheter associated urinary tract infections CAUTIs are often encountered with subsequent
antibiotic administration contributing to buildup of bacterial resistance Leaving behind
customary methods including release of silver and antimicrobials PEG LLC is developing a new
approach to produce catheters that kill bacteria but are compatible with human cells The
promise of this new overcoat method is not based on any single characteristic but on an
unprecedented combination of features These include an intelligent choice for economical
chemistry and processing Proposed Phase II research is based on a promising paradigm
breaking approach coupled with in vitro and in vivo evaluations designed to assess feasibility
and FDA requirements A strong interdisciplinary team is dedicated to bottoms up biomaterials
engineering that fills a strong need in the face of top down requirements to achieve such
unprecedented capabilities economically Indeed PEG LLC research promises to have a major
impact not only on improving patient outcomes but in providing an economic benefit in reducing
the rapidly rising cost of medical care
Key Words catheters overcoat cell compatibility antimicrobial Polymer Exploration Group LLC Phase II Project Narrative
NIH SBIR Award R DK A
Project Narrative Relevance
Infection is a serious medical complication associated with health care environments Catheter
associated urinary tract infections CAUTIs are important contributors to such infections with
estimates ranging from Women those with strokes the disabled and the elderly are
particularly susceptible to CAUTIs Polymer Exploration Group PEG LLC is developing a new
approach to greatly reduce the incidence of CAUTIs The new PEG LLC approach does not use
antibiotics or antimicrobials that lead to super bugs PEG LLC also avoids heavy metals like
silver In summary PEG LLC is aiming to eliminate infections with comfort and safety for
patients Results thus far show exciting promise for bringing much needed innovation to
catheter technology
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- A platform for T-cell receptor mimic antibody generation modeled using pHLA-A*11:01 KRAS G12D
- Combinatorial pipeline for discovery of anti-GPCR Nanobodies
- Development of a GBP-based glycosylation analysis system
- Extended-release injectable gel for multi-day treatment of postoperative pain
- eMOA: A Multi-Omic Service for Mechanism of Action Determination in Drug Screening